High-dose-rate brachytherapy for cervical cancer after subtotal hysterectomy using standardized applicators cannot achieve a good absorbed-dose coverage of the target volume in special tumor morphologies and topographies due to the steep dose gradient. The aim of this pictorial essay is to present an individualized cylindrical vaginal applicator with oblique guide holes using 3D modeling and printing technologies used at the China-Japan Union Hospital of Jilin University for cervical cancer patients. We use images to describe the steps of this method.
Purpose
External beam radiotherapy (EBRT), concomitant chemotherapy, and brachytherapy is the modern treatment modality for advanced cervical cancer. Brachytherapy is an integral part of radiation treatment of cervical cancer. Studies have shown a clear dose-volume effect between modern dosimetric parameters (D 90 of high-risk clinical target volume [HR-CTV] and intermediate-risk clinical target volume [IR-CTV]) and the probability of achieving local control [1, 2] . For cervical cancer brachytherapy, common standardized applicators include tandem and ring applicators, tandem and ovoid applicators, vaginal cylinders, combined intracavitary and interstitial (IC/IS) applicators, and the Martinez universal perineal interstitial template [3, 4, 5, 6] . Each applicator has its own unique structural characteristics and is applicable to a specific situation.
For special tumor morphology and topography, brachytherapy cannot achieve a good absorbed-dose coverage of the target volume for using standardized applicators due to a steep dose gradient, thereby not achieving good local control. Many studies have made many attempts in the field of individualized applicators and have achieved good results [7, 8, 9, 10] . The aim of this pictorial essay is to demonstrate the workflow of an individualized cylindrical vaginal applicator with oblique guide holes using 3D modeling and printing technologies.
Material and methods
A 47-year-old woman was diagnosed with stage IIIA cervical cancer after having a subtotal hysterectomy for uterine fibroids 10 years prior. A gynecological examination and magnetic resonance imaging (MRI) showed that the tumor was located at the anterior lip of the cervix, the upper one-third of the anterior wall of the vagina, and the left onethird of the parauterine organ, with a size of 5.6 × 3 × 3.8 cm 3 . The dose of EBRT was 45 Gy/25 fractions delivered by intensity-modulated radiation therapy. After EBRT, a gynecological examination showed that the tumor involved the upper one-third of the anterior vaginal wall with a 2 cm maximum extension in depth. In consideration of her stenotic vagina and tumor location, we applied the individualized vaginal cylinder applicator with guide holes. The design of the applicator was based on the preplanning steps: computed tomography (CT) simulation and contour ( Figure 1 ), establishment of coordinate system of the applicator (Figure 2 ), optimized design of needle path (Figures 3-5 ), and dose distribution optimization ( Figure 6 ). The delineation of the target volumes was contoured according to recommendations from the GYN GEC-ESTRO Working Group [11] . Data on the direction for the needles based on the coordinate system are shown in Table 1 . According to the data from the preplanning phase, the 3D modeling of the applicator (Figures 7-10) was implemented in 3ds Max (2015 version, Autodesk Inc., San Rafael, CA, USA). The 3D printing process of the To design convenient directions of the implanted needles, we established the coordinate system of the applicator as follows: the x-axis is the left and right direction, where the left of the patient is positive; the z-axis is the anterior and posterior direction, where the anterior of the patient is positive; the y-axis is the head and foot direction, and the head of the patient is positive. We designed an ideal implanted needle according to the relationship between the tumor (red coil) and the vaginal cylinder (blue) while considering the needle distribution. Two points determine a straight line (the implant needle). The superior point is called the "tip end", and the inferior point is called the "base end" Figures 11-13 . The implantation of the applicator and the needles was performed under the guidance of transrectal ultrasound in every application. We used the following brachytherapy treatment schema: 4 fractions, 7 Gy/fraction; 1 week apart for total treatment time of 57 days (including EBRT).
Results
An example (the first fraction) of the relationship between the isodose curves and the target volumes or organs at risk (OARs) is shown in Figure 14 . The DVH parameters for all the treatment plans, including the preplanning phase, are shown in Table 2 . Brachytherapy was well tolerated and achieved a satisfactory total equivalent dose in 2 Gy/fraction (EQD 2 ) for HR-CTV. At the last follow-up at 24 months after brachytherapy, there was no evidence of recurrence in the pelvic region and no signs or symptoms of complications (see Figure 15 ).
Discussion
In conventional 2D brachytherapy, individualized treatment cannot be achieved. The use of 3D brachytherapy shows a trend towards increased local control and improved overall survival with reduced toxicity compared to 2D brachytherapy [12] . At present, individualized treatment is a recommended strategy for cervical cancer brachytherapy in the modern management of cervical cancer [8, 13] . This paper introduced the design and application of an individualized cylindrical vaginal applicator using 3D modeling and printing technologies and Table 1 Fig . 9 . II. 3D modeling: A cylindrical applicator with oblique guide holes was obtained using Boolean subtraction Fig. 15 . IV. Clinical outcome: MRI showed no evidence of recurrence in the pelvic region at A) 9 months, B) 12 months, C) 16 months, and D) 24 months after brachytherapy achieved good clinical results. This paper introduces only the production process of the individualized vaginal cylindrical applicators. The specific 3D modeling software and 3D printer used in this study are replaceable. As long as other software and hardware have the corresponding functions, they can be used to replace the software and hardware introduced in this paper. In the preplanning phase, the delineation of target volumes and OARs is not directly based on MRI but on CT images cross-referenced with an MRI image. Although this method is not the best strategy, it is an acceptable secondary option to some extent. Readers can follow the workflow of this study and perform the preplanning phase based on MRI, which will bring more optimized results. In this study, the design of an individualized cylindrical vaginal applicator was based on the data acquired in the preplanning phase, which is an effective method, and preplanning is also recommended in all brachytherapy plans [14] . Four fractions of brachytherapy achieved the ideal dose distribution. Figure 6 shows that the isodose line of the prescribed dose covered the HR-CTV well and avoided OARs well. From Table 2 , it can be seen that the total EQD 2 of the target volumes and the OARs all achieved the limit dose, and 5 of the 7 items achieved the planning aim dose. This result fully shows that the individualized cylindrical vaginal applicator using 3D modeling and printing technologies has good availability, practicability and repeatability.
For cervical cancer brachytherapy after subtotal hysterectomy, cylindrical vaginal applicators are commonly used applicators. Because of the high dose gradient in brachytherapy, when the depth of vaginal infiltration is far greater than 5 mm, it is impossible to achieve both a high dose coverage of the prescribed dose for the target volumes and a low dose to OARs [6] . The individualized applicator introduced in this paper can be used for deep vaginal invasion, vaginal tumors with asymmetric growth, vaginal recurrences, and vaginal cuff recurrence after subtotal hysterectomy.
Conclusions
When standardized applicators cannot achieve a good dose distribution for cervical cancer after subtotal hysterectomy, one can achieve a higher dose coverage of the target and better sparing of the OARs by using a 3D-printed, individualized cylindrical vaginal applicator.
